APOA5 Antibody
- Known as:
- APOA5 Antibody
- Catalog number:
- AF1075a
- Product Quantity:
- 0.1mg
- Category:
- -
- Supplier:
- Abgen
- Gene target:
- APOA5 Antibody
Ask about this productRelated genes to: APOA5 Antibody
- Gene:
- APOA5 NIH gene
- Name:
- apolipoprotein A5
- Previous symbol:
- -
- Synonyms:
- RAP3, APOA-V
- Chromosome:
- 11q23.3
- Locus Type:
- gene with protein product
- Date approved:
- 2001-12-11
- Date modifiied:
- 2016-10-05
Related products to: APOA5 Antibody
Related articles to: APOA5 Antibody
- - Source: PubMed
Publication date: 2026/08/23
Liu Yu-LinXiang ZhuoZhang Bo-YaZou Yu-WeiChen Gui-LaiYin LiShi Yan-LongXu Li-LiBi JingwangWang Qiang - Labour dystocia (LAD) in sows is a common reproductive disorder that reduces piglet survival rates and increases the number of stillbirths, causing substantial economic losses to pig farms. However, the genetic basis of LAD remains elusive. Herein, we performed a single-breed genome-wide association study (GWAS) for LAD using imputed whole-genome sequence data from 3263 sows (487 Landrace and 2776 Yorkshire). - Source: PubMed
Publication date: 2026/08/09
Zhou ShenpingHan JinyiYuan JingliQiao ChuanminChao ZheDuan DongdongLi MengyuWang ZhenyuTan ShuyiLi XinjianXin Wenshui - Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder characterized by severe hypertriglyceridemia (sHTG) due to variants in canonical genes (LPL [lipoprotein lipase], APOA5, APOC2, GPIHBP1, and LMF1); its genotype distribution in Latin America remains scarcely reported. Given limited access to genetic testing and frequent negative results in clinically consistent cases, clinical scores and lipid ratios have been proposed to predict FCS. - Source: PubMed
Publication date: 2026/07/10
Fariña GregorioSleiman AmiraAlonso RodrigoGutiérrez Restrepo JonhayroSpagnuolo CamilaAgudelo Valencia NataliaGonzález Moore JosefinaSánchez Peñarete DianaSchvarzman NadiaGonzález Alejandro RománMonsalve ClaudiaCuevas AdaMelnik Luciana YennyCastaño Ceballos Pablo AlbertoLavalle Cobo AugustoEsteban Eduardo OsvaldoAimone DanielCastellanos Pinedo AlejandroNogueira Juan PatricioBerg Gabriela - Most drugs target proteins, and proteome-wide genetic analyses in diverse populations could discover potential novel and repurposed targets for improved prevention and treatment of ischemic heart disease (IHD) beyond statin therapy. - Source: PubMed
Publication date: 2026/07/20
Mazidi MohsenWright NeilPozarickij AlfredMillwood Iona YWalters RobinKartsonaki ChristianaBennett Derrick AYao PangDu HuaidongFry HannahYu CanqingIona AndriWang BaihanChen YipingSun DianjianyiYang LingLv JunIm Pek KeiAvery DanielGoel AnujWatkins HughWang HaoKyriakou TheodosiosBrennan PaulPeto RichardCollins RoryLi LimingClarke RobertChen Zhengming - Chylomicronemia is a genetically heterogeneous condition with both genetic and environmental determinants. Genetic studies have largely focused on European populations, with limited data from East Asians, particularly Han Chinese. We characterized the genetic profiles of chylomicronemia patients of mainly Han Chinese ancestry in Taiwan. - Source: PubMed
Publication date: 2026/07/10
Chao Eric Bo-RuJhan Siao-JyuanLin Po-ChihChou Yuh-TsyrChang Wen-ChiLuo Allen ChilunLin Mao-JanKuo Ching-HuaChen Yu-AnChen Pei-LungSu Ta-Chen